Insider Activity Spotlight: Carlyle Group Inc-The
Recent Transaction Overview On February 1, 2026, Co‑President John C. Redett executed a sell of 2,926 shares of Carlyle common stock. The sale occurred at a price of $58.78—slightly below the market close of $60.36—while the company’s share price was down 3.4% that week. In the same filing, Redett also purchased 273,973 restricted‑stock‑unit (RSU) shares that will vest over 2027‑2029, and 12,965 additional RSUs vesting in 2027‑2029. These simultaneous sell and buy‑to‑vest moves suggest a short‑term liquidity need paired with a long‑term commitment to the firm’s equity plan.
Implications for Investors The modest cash sale may signal routine portfolio rebalancing rather than a loss of confidence, especially given the strong RSU commitments. However, the timing—just before a quarterly earnings report—could be interpreted as a pre‑earnings liquidity maneuver. Investors should watch for subsequent filings: a pattern of early‑quarter RSU purchases could indicate insider optimism, while a surge in short‑term sales might raise concerns about cash flow pressures or personal wealth management needs.
Redett’s Insider Profile Redett’s historical trading record paints him as an investor who favors long‑term equity exposure. On December 17, 2025, he bought 550,965 shares at $0.00 (RSU purchase), bringing his post‑transaction holdings to 1,651,081 shares. The current sale of 2,926 shares is a negligible fraction (≈0.18%) of his total stake, underscoring a strategy that balances liquidity with a substantial equity position. Compared with peers—such as Co‑President Mark David who sold 5,812 shares and bought 144,488 shares the same day—Redett’s activity is relatively conservative.
Broader Insider Activity Context Other senior executives on February 1 also engaged in mixed sell/buy patterns: CEO Harvey Schwartz sold 578,862 shares and purchased none; CFO Justin Plouffe sold 2,792 shares and bought 40,770 shares; COO Lindsay LoBue sold 2,128 shares and bought 114,156 shares. The cohort’s collective activity indicates a trend of short‑term liquidating followed by strategic RSU accumulation—a common practice among senior management to fund personal liquidity while maintaining a vested interest in company performance.
Future Outlook for Carlyle Carlyle’s recent asset disposals (e.g., Arctic Glacier stake sale) and potential new investor base in the UAE suggest an active portfolio realignment. With a 52‑week high of $69.85 and current price near $60, the firm remains well‑capitalized, and its RSU grants could serve as a positive signal of insider confidence. Analysts citing Carlyle as a buy opportunity ahead of earnings further reinforce the narrative that insider activity, while notable, may not foreshadow a decline but rather a strategic repositioning.
Investors should monitor Redett’s subsequent filings—particularly any significant sell waves or additional RSU purchases—to gauge whether this February activity represents a one‑off liquidity move or the start of a broader insider trend. The combination of insider RSU commitments, modest cash sales, and Carlyle’s active asset management points to a firm that is both confident in its long‑term trajectory and responsive to short‑term liquidity needs.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-02-01 | Redett John C. (Co-President) | Sell | 2,926.00 | 58.78 | Common Stock |
| 2026-02-01 | Redett John C. (Co-President) | Buy | 273,973.00 | N/A | Common Stock |
| 2026-02-01 | Redett John C. (Co-President) | Buy | 12,965.00 | N/A | Common Stock |
| 2026-02-01 | Jenkins Mark David (Co-President) | Sell | 5,812.00 | 58.78 | Common Stock |
| 2026-02-01 | Jenkins Mark David (Co-President) | Buy | 144,488.00 | N/A | Common Stock |
| 2026-02-01 | Jenkins Mark David (Co-President) | Buy | 12,965.00 | N/A | Common Stock |
| 2026-02-01 | Andrews Charles Elliott Jr. (Chief Accounting Officer) | Sell | 1,084.00 | 58.78 | Common Stock |
| 2026-02-01 | Andrews Charles Elliott Jr. (Chief Accounting Officer) | Buy | 15,493.00 | N/A | Common Stock |
| 2026-02-01 | Andrews Charles Elliott Jr. (Chief Accounting Officer) | Buy | 7,747.00 | N/A | Common Stock |
| 2026-02-01 | LoBue Lindsay (Chief Operating Officer) | Sell | 2,128.00 | 58.78 | Common Stock |
| 2026-02-01 | LoBue Lindsay (Chief Operating Officer) | Buy | 114,156.00 | N/A | Common Stock |
| 2026-02-01 | LoBue Lindsay (Chief Operating Officer) | Buy | 12,965.00 | N/A | Common Stock |
| 2026-02-01 | Nedelman Jeffrey (Co-President) | Sell | 6,092.00 | 58.78 | Common Stock |
| 2026-02-01 | Nedelman Jeffrey (Co-President) | Buy | 217,303.00 | N/A | Common Stock |
| 2026-02-01 | Nedelman Jeffrey (Co-President) | Buy | 12,965.00 | N/A | Common Stock |
| 2026-02-01 | Ferguson Jeffrey W. (General Counsel) | Sell | 503.00 | 58.78 | Common Stock |
| 2026-02-01 | Ferguson Jeffrey W. (General Counsel) | Buy | 24,462.00 | N/A | Common Stock |
| 2026-02-01 | Ferguson Jeffrey W. (General Counsel) | Buy | 3,181.00 | N/A | Common Stock |
| 2026-02-01 | SCHWARTZ HARVEY M (Chief Executive Officer) | Sell | 578,862.00 | 58.78 | Common Stock |
| 2026-02-01 | Plouffe Justin (Chief Financial Officer) | Sell | 2,792.00 | 58.78 | Common Stock |
| 2026-02-01 | Plouffe Justin (Chief Financial Officer) | Buy | 40,770.00 | N/A | Common Stock |
| 2026-02-01 | Plouffe Justin (Chief Financial Officer) | Buy | 9,704.00 | N/A | Common Stock |




